FDA Adverse Event Injury Summary report: N

STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON

MDR report key: 8784850 · Received July 12, 2019

Report

Report Number
3009784280-2019-00505
Event Type
Injury
Date Received
July 12, 2019
Date of Event
December 7, 2018
Report Date
June 21, 2019
Manufacturer
SPECTRANETICS
Product Code
ONU
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT REQUIRED AMPUTATION ON THE TREATED LIMB. THIS IS BEING REPORTED AS A FOLLOW-UP TO THE CLINICAL REGISTRY. PATIENT INFORMATION REGARDING RELEVANT TESTS OR LABORATORY DATA IS UNKNOWN. THIS INFORMATION WAS NOT AVAILABLE FROM THE FACILITY. REPORT SOURCE: FOREIGN- (B)(6)/ STUDY NAME: (B)(6)- PATIENT ID # (B)(6). PMA NUMBER IS NOT APPLICABLE. THE DEVICE IS A COMMERCIAL PRODUCT WITH A CE MARK THAT WAS USED AS PART OF A CLINICAL REGISTRY. DURING THE INDEX PROCEDURE, THE PRODUCT WORKED AS INTENDED, THUS NO PRODUCT EVALUATION WAS REQUIRED. PER THE IFU, AMPUTATION IS LISTED AS POTENTIAL COMPLICATIONS/ADVERSE EVENTS.

Description of Event or Problem · 1

IT WAS REPORTED THROUGH A CLINICAL REGISTRY THAT DURING THE INDEX PROCEDURE ON (B)(6) 2018, TWO STELLAREX CATHETERS WERE USED TO TREATED THE TARGET LESION OF THE LEFT MID SFA. APPROXIMATELY 8 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED ATHEROSCLEROSIS OF EXTREMITIES WITH GANGRENE. A MINOR AMPUTATION OF THE LEFT FRONT FOOT WAS PERFORMED ON (B)(6) 2018. THE PHYSICIAN INDICATED THIS IS NOT RELATED TO THE STUDY DEVICE OR PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
578355 STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON DCB PTA CATHETER ONU SPECTRANETICS A35SX060040080 FBZ17D10A

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| R